Capital Fund Management (CFM)’s Gilead Sciences GILD Stock Holding History

Capital Fund Management (CFM)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.3M	Buy	73,592 +36,156	+97%	+$5.06M	0.05%	542
2025 Q4	$4.59M	Buy	+37,436	New	+$4.55M	0.01%	1226
2025 Q3	–	Sell	-14,467	Closed	-$1.64M	–	2541
2025 Q2	$1.6M	Buy	+14,467	New	+$1.54M	﹤0.01%	1790
2025 Q1	–	Sell	-29,764	Closed	-$3.07M	–	2135
2024 Q4	$2.75M	Sell	29,764 -443,752	-94%	-$40M	0.01%	1366
2024 Q3	$39.7M	Buy	473,516 +427,399	+927%	+$32.6M	0.11%	250
2024 Q2	$3.16M	Sell	46,117 -1,088,645	-96%	-$72.7M	0.01%	1179
2024 Q1	$83.1M	Buy	1,134,762 +686,384	+153%	+$52.8M	0.24%	96
2023 Q4	$36.3M	Buy	448,378 +383,410	+590%	+$29.8M	0.1%	286
2023 Q3	$4.87M	Buy	+64,968	New	+$5M	0.02%	946
2023 Q2	–	Sell	-51,707	Closed	-$4.12M	–	1753
2023 Q1	$4.29M	Sell	51,707 -114,717	-69%	-$9.5M	0.02%	780
2022 Q4	$14.3M	Sell	166,424 -156,445	-48%	-$12.4M	0.1%	293
2022 Q3	$19.9M	Sell	322,869 -38,145	-11%	-$2.41M	0.16%	163
2022 Q2	$22.3M	Sell	361,014 -76,246	-17%	-$4.72M	0.2%	114
2022 Q1	$26M	Buy	437,260 +45,939	+12%	+$2.94M	0.21%	116
2021 Q4	$28.4M	Buy	391,321 +141,649	+57%	+$9.76M	0.2%	119
2021 Q3	$17.4M	Sell	249,672 -24,111	-9%	-$1.69M	0.13%	205
2021 Q2	$18.9M	Buy	+273,783	New	+$18.3M	0.15%	166
2020 Q3	–	Sell	-21,923	Closed	-$1.52M	–	1275
2020 Q2	$1.69M	Buy	+21,923	New	+$1.68M	0.03%	552
2020 Q1	–	Sell	-73,260	Closed	-$4.76M	–	1736
2019 Q4	$4.76M	Buy	+73,260	New	+$4.77M	0.04%	552
2019 Q3	–	Sell	-9,727	Closed	-$657K	–	1757
2019 Q2	$657K	Sell	9,727 -221,421	-96%	-$14.6M	0.01%	1133
2019 Q1	$15M	Buy	231,148 +209,911	+988%	+$14M	0.13%	226
2018 Q4	$1.33M	Buy	+21,237	New	+$1.48M	0.01%	1003
2017 Q3	–	Sell	-152,908	Closed	-$11.7M	–	1605
2017 Q2	$10.8M	Buy	152,908 +68,562	+81%	+$4.56M	0.09%	283
2017 Q1	$5.73M	Sell	84,346 -514,657	-86%	-$36.2M	0.05%	424
2016 Q4	$42.9M	Sell	599,003 -114,730	-16%	-$8.53M	0.37%	58
2016 Q3	$56.5M	Buy	713,733 +314,907	+79%	+$25.6M	0.52%	35
2016 Q2	$33.3M	Sell	398,826 -627,813	-61%	-$55.7M	0.31%	78
2016 Q1	$94.3M	Buy	1,026,639 +917,025	+837%	+$82.7M	0.92%	7
2015 Q4	$11.1M	Buy	109,614 +55,142	+101%	+$5.74M	0.11%	242
2015 Q3	$5.35M	Sell	54,472 -84,076	-61%	-$9.34M	0.06%	377
2015 Q2	$16.2M	Buy	138,548 +65,879	+91%	+$7.2M	0.21%	133
2015 Q1	$7.13M	Buy	72,669 +66,069	+1,001%	+$6.71M	0.1%	258
2014 Q4	$622K	Buy	6,600 +2,800	+74%	+$290K	0.01%	1051
2014 Q3	$405K	Buy	+3,800	New	+$372K	﹤0.01%	1222
2014 Q2	–	Sell	-120,505	Closed	-$9.38M	–	1762
2014 Q1	$8.54M	Buy	+120,505	New	+$9.45M	0.1%	229
2013 Q3	–	Sell	-349,180	Closed	-$20.9M	–	1690
2013 Q2	$17.9M	Buy	+349,180	New	+$18.2M	0.27%	59

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital Fund Management (CFM)'s GILD Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Gilead Sciences (GILD) stake by 97% in Q1 2026, buying an estimated $5.06M and bringing the position to 73,592 shares worth $10.3M. The position accounts for 0.05% of the portfolio, ranked #542.

Capital Fund Management (CFM) first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $94.3M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Capital Fund Management (CFM) held 73,592 shares of Gilead Sciences worth $10.3M as of Q1 2026.
Capital Fund Management (CFM) bought 36,156 Gilead Sciences shares in Q1 2026, an estimated $5.06M.
Gilead Sciences made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #542 holding.
Capital Fund Management (CFM) first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
Capital Fund Management (CFM)'s Gilead Sciences position peaked at $94.3M in Q1 2016.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.